Rheonix: Stephen Thomas
Jul 21, 2022
Molecular diagnostic testing company Rheonix has appointed Stephen Thomas as chief medical officer and a member of the firm's board. He is a professor of medicine and microbiology and immunology at SUNY Upstate Medical University and directs the Institute for Global Health and Translational Science. He is also interim chair of the department of microbiology and immunology. Additionally, Thomas is the global coordinating principal investigator for Pfizer's Phase 1/2/3 COVID vaccine trial.